KR101041437B1 - 혈관질환 예방 또는 개선용 조성물 - Google Patents
혈관질환 예방 또는 개선용 조성물 Download PDFInfo
- Publication number
- KR101041437B1 KR101041437B1 KR1020090080585A KR20090080585A KR101041437B1 KR 101041437 B1 KR101041437 B1 KR 101041437B1 KR 1020090080585 A KR1020090080585 A KR 1020090080585A KR 20090080585 A KR20090080585 A KR 20090080585A KR 101041437 B1 KR101041437 B1 KR 101041437B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- weight
- extract
- sample
- sewage
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 101
- 208000019553 vascular disease Diseases 0.000 title claims abstract description 35
- 206010059245 Angiopathy Diseases 0.000 title 1
- 239000010865 sewage Substances 0.000 claims abstract description 68
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 17
- 241000287828 Gallus gallus Species 0.000 claims abstract description 17
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 17
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 17
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 17
- 229940010454 licorice Drugs 0.000 claims abstract description 17
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 16
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 16
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract description 16
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 16
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 16
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 16
- 235000008397 ginger Nutrition 0.000 claims abstract description 16
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 230000007812 deficiency Effects 0.000 claims abstract description 6
- 244000273928 Zingiber officinale Species 0.000 claims abstract 3
- 240000008866 Ziziphus nummularia Species 0.000 claims abstract 3
- 238000000034 method Methods 0.000 claims description 16
- 241000202807 Glycyrrhiza Species 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 230000006806 disease prevention Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 27
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 230000003078 antioxidant effect Effects 0.000 abstract description 7
- 208000007536 Thrombosis Diseases 0.000 abstract description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 52
- 210000004027 cell Anatomy 0.000 description 35
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 33
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- 241001247821 Ziziphus Species 0.000 description 14
- 241000234314 Zingiber Species 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- 238000002835 absorbance Methods 0.000 description 11
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 10
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 10
- 230000035755 proliferation Effects 0.000 description 10
- 239000000872 buffer Substances 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 8
- 229930003268 Vitamin C Natural products 0.000 description 8
- 238000006911 enzymatic reaction Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 235000019154 vitamin C Nutrition 0.000 description 8
- 239000011718 vitamin C Substances 0.000 description 8
- 244000269722 Thea sinensis Species 0.000 description 7
- 230000002000 scavenging effect Effects 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000008188 pellet Substances 0.000 description 6
- 230000002537 thrombolytic effect Effects 0.000 description 6
- 102000009123 Fibrin Human genes 0.000 description 5
- 108010073385 Fibrin Proteins 0.000 description 5
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 5
- 229950003499 fibrin Drugs 0.000 description 5
- 210000001589 microsome Anatomy 0.000 description 5
- 108090000854 Oxidoreductases Proteins 0.000 description 4
- 102000004316 Oxidoreductases Human genes 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000001516 cell proliferation assay Methods 0.000 description 4
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- 230000003013 cytotoxicity Effects 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 229940012957 plasmin Drugs 0.000 description 4
- 238000011533 pre-incubation Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 3
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 3
- 238000000719 MTS assay Methods 0.000 description 3
- 231100000070 MTS assay Toxicity 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 244000000231 Sesamum indicum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 229910021538 borax Inorganic materials 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000010339 sodium tetraborate Nutrition 0.000 description 3
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 3
- CABVTRNMFUVUDM-VRHQGPGLSA-N (3S)-3-hydroxy-3-methylglutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](O)(CC(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CABVTRNMFUVUDM-VRHQGPGLSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 102400000967 Bradykinin Human genes 0.000 description 2
- 101800004538 Bradykinin Proteins 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 2
- PMWSGVRIMIFXQH-KKUMJFAQSA-N His-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1NC=NC=1)C1=CN=CN1 PMWSGVRIMIFXQH-KKUMJFAQSA-N 0.000 description 2
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 2
- 241001365789 Oenanthe crocata Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229940106780 human fibrinogen Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- 231100001083 no cytotoxicity Toxicity 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 102400000344 Angiotensin-1 Human genes 0.000 description 1
- 101800000734 Angiotensin-1 Proteins 0.000 description 1
- 102400000345 Angiotensin-2 Human genes 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 101150071434 BAR1 gene Proteins 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- MMFKFJORZBJVNF-UWVGGRQHSA-N His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 MMFKFJORZBJVNF-UWVGGRQHSA-N 0.000 description 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 210000000593 adipose tissue white Anatomy 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- ORWYRWWVDCYOMK-HBZPZAIKSA-N angiotensin I Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 ORWYRWWVDCYOMK-HBZPZAIKSA-N 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229960003766 thrombin (human) Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Abstract
Description
구분 |
적하수오 추출물 (중량%) |
약쑥 (중량%) |
대추 (중량%) |
감초 (중량%) |
육계 (중량%) |
생강 (중량%) |
결명자 (중량%) |
80% 에탄올에 용해된 적하수오 추출물의 농도 (%) |
조성물 1 | 40 |
10 |
10 |
10 |
10 |
10 |
10 |
0.01 |
조성물 2 | 0.05 | |||||||
조성물 3 | 0.1 | |||||||
조성물 4 | 0.3 | |||||||
조성물 5 | 0.6 | |||||||
조성물 6 | 1 | |||||||
구분 |
백하수오 추출물 (중량%) |
약쑥 (중량%) |
대추 (중량%) |
감초 (중량%) |
육계 (중량%) |
생강 (중량%) |
결명자 (중량%) |
80% 에탄올에 용해된 백하수오 추출물의 농도 (%) |
조성물 7 | 40 |
10 |
10 |
10 |
10 |
10 |
10 |
0.01 |
조성물 8 | 0.05 | |||||||
조성물 9 | 0.1 | |||||||
조성물 10 | 0.3 | |||||||
조성물 11 | 0.6 | |||||||
조성물 12 | 1 |
구분 |
적하수오 추출물 (중량%) |
약쑥 (중량%) |
대추 (중량%) |
감초 (중량%) |
육계 (중량%) |
생강 (중량%) |
결명자 (중량%) |
DMSO에 용해된 적하수오 추출물의 농도 (ppm) |
조성물A | 22 |
13 |
13 |
13 |
13 |
13 |
13 |
10 |
조성물B | 100 | |||||||
조성물C | 1,000 | |||||||
조성물D | 10,000 | |||||||
구분 |
백하수오 추출물 (중량%) |
약쑥 (중량%) |
대추 (중량%) |
감초 (중량%) |
육계 (중량%) |
생강 (중량%) |
결명자 (중량%) |
DMSO에 용해된 백하수오 추출물의 농도 (ppm) |
조성물E | 22 |
13 |
13 |
13 |
13 |
13 |
13 |
10 |
조성물F | 100 | |||||||
조성물G | 1,000 | |||||||
조성물H | 10,000 |
시료 | DMSO에 용해된 추출물의 농도(ppm) | Inhibition activity(%) | |
적하수오 추출물 |
조성물 A | 10 | -182.7±22.3 |
조성물 B | 100 | -72.3±12.1 | |
조성물 C | 1,000 | 77.92±8.2 | |
조성물 D | 10,000 | 92.61±4.2 | |
백하수오 추출물 |
조성물 E | 10 | -391.2±45.9 |
조성물 F | 100 | -62.9±12.1 | |
조성물 G | 1,000 | 49.03±2.1 | |
조성물 H | 10,000 | 85.27±9.4 |
시료 | DMSO에 용해된 추출물의 농도(ppm) | Inhibition activity(%) | |
적하수오 추출물 |
조성물 A | 10 | -2.1±0.01 |
조성물 B | 100 | 10.5±2.1 | |
조성물 C | 1,000 | 17.3±1.3 | |
조성물 D | 10,000 | 52.9±3.7 | |
백하수오 추출물 |
조성물 E | 10 | -3.2±0.04 |
조성물 F | 100 | 6.6±0.7 | |
조성물 G | 1,000 | 5.2±0.5 | |
조성물 H | 10,000 | 29.5±3.0 |
시료 | DMSO에 용해된 추출물의 농도(mg/mL) | 투명환 크기(cm2) | |
적하수오 추출물 |
시료 1 | 25 | 0.785 |
시료 2 | 50 | 0.785 | |
시료 3 | 100 | 0.950 | |
시료 4 | 200 | 1.327 | |
백하수오 추출물 |
시료 5 | 25 | 0.785 |
시료 6 | 50 | 0.950 | |
시료 7 | 100 | 0.636 | |
시료 8 | 200 | 0.950 | |
대조군 |
plasmin(μg) | 투명환 크기(cm2) | |
5 | 0.785 | ||
10 | 1.327 | ||
15 | 2.010 | ||
20 | 2.404 |
구분 | 하수오 추출물 | 농도(μg/mL) |
대조군 | 처리하지 않음 | 0 |
시료 (가1) | 80% 에탄올에 용해된 적하수오 추출물을 처리함 |
25 |
시료 (나1) | 50 | |
시료 (다1) | 100 | |
시료 (라1) | 150 | |
시료 (마1) | 200 | |
시료 (바1) | 80% 에탄올에 용해된 백하수오 추출물을 처리함 |
25 |
시료 (사1) | 50 | |
시료 (아1) | 100 | |
시료 (자1) | 150 | |
시료 (차1) | 200 |
구분 | 하수오 추출물 | 농도(μg/mL) |
대조군 | 처리하지 않음 | 0 |
시료 (가2) | 80% 에탄올에 용해된 적하수오 추출물을 처리함 |
25 |
시료 (나2) | 50 | |
시료 (다2) | 100 | |
시료 (라2) | 150 | |
시료 (마2) | 200 | |
시료 (바2) | 80% 에탄올에 용해된 백하수오 추출물을 처리함 |
25 |
시료 (사2) | 50 | |
시료 (아2) | 100 | |
시료 (자2) | 150 | |
시료 (차2) | 200 |
Claims (4)
- 하수오 추출물, 약쑥, 대추, 감초, 육계, 생강 및 결명자를 포함하는 혈관질환 예방 또는 개선용 조성물.
- 제 1 항에 있어서,하수오 추출물 0.01 ~ 88 중량%, 약쑥 2 ~ 16.33 중량%, 대추 2 ~ 16.33 중량%, 감초 2 ~ 16.33 중량%, 육계 2 ~ 17 중량%, 생강 2 ~ 17 중량% 및 결명자 2 ~ 17 중량%를 포함하는 혈관질환 예방 또는 개선용 조성물.
- 제 1 항에 있어서,상기 하수오 추출물은 적하수오 추출물 및 백하수오 추출물로 구성된 그룹에서 선택된 1종 또는 2종의 혼합물인 것을 특징으로 하는 혈관질환 예방 또는 개선용 조성물.
- 제 1 항에 있어서,상기 하수오 추출물은, 하수오를 물로 추출한 후 감압농축한 것을 특징으로 하는 혈관질환 예방 또는 개선용 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090080585A KR101041437B1 (ko) | 2009-08-28 | 2009-08-28 | 혈관질환 예방 또는 개선용 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090080585A KR101041437B1 (ko) | 2009-08-28 | 2009-08-28 | 혈관질환 예방 또는 개선용 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110023015A KR20110023015A (ko) | 2011-03-08 |
KR101041437B1 true KR101041437B1 (ko) | 2011-06-15 |
Family
ID=43931208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090080585A KR101041437B1 (ko) | 2009-08-28 | 2009-08-28 | 혈관질환 예방 또는 개선용 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101041437B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200053015A (ko) | 2018-11-07 | 2020-05-18 | 이효준 | 붓기 제거에 효과가 있는 식물성 천연물의 혼합 추출물을 포함하는 혈전증의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102298129B1 (ko) * | 2019-11-14 | 2021-09-06 | 한경수 | 한방 혼합물을 유효성분으로 함유하는 혈전증의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010077956A (ko) * | 2000-02-08 | 2001-08-20 | 배석태 | 하수오에서 항산화 성분을 추출하는 방법, 하수오 추출물및 하수오 추출물 또는 하수오 분말을 포함하는 건강식품 |
KR20030055127A (ko) * | 2001-12-24 | 2003-07-02 | 주식회사 닥터즈메디코아 | 항고지혈증 조성물 |
KR20080027050A (ko) * | 2006-09-22 | 2008-03-26 | 충북대학교 산학협력단 | 높은 항산화성 쑥엑기스의 특성 및 제조법 |
KR20100046639A (ko) * | 2008-10-28 | 2010-05-07 | 원광대학교산학협력단 | 백하수오 추출물을 유효 성분으로 하는 심혈관계 질환 및 고지혈증의 예방과 개선을 위한 조성물 |
-
2009
- 2009-08-28 KR KR1020090080585A patent/KR101041437B1/ko active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010077956A (ko) * | 2000-02-08 | 2001-08-20 | 배석태 | 하수오에서 항산화 성분을 추출하는 방법, 하수오 추출물및 하수오 추출물 또는 하수오 분말을 포함하는 건강식품 |
KR20030055127A (ko) * | 2001-12-24 | 2003-07-02 | 주식회사 닥터즈메디코아 | 항고지혈증 조성물 |
KR20080027050A (ko) * | 2006-09-22 | 2008-03-26 | 충북대학교 산학협력단 | 높은 항산화성 쑥엑기스의 특성 및 제조법 |
KR20100046639A (ko) * | 2008-10-28 | 2010-05-07 | 원광대학교산학협력단 | 백하수오 추출물을 유효 성분으로 하는 심혈관계 질환 및 고지혈증의 예방과 개선을 위한 조성물 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200053015A (ko) | 2018-11-07 | 2020-05-18 | 이효준 | 붓기 제거에 효과가 있는 식물성 천연물의 혼합 추출물을 포함하는 혈전증의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품 |
Also Published As
Publication number | Publication date |
---|---|
KR20110023015A (ko) | 2011-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alachaher et al. | Comparison of phytochemical and antioxidant properties of extracts from flaxseed (Linum usitatissimum) using different solvents. | |
Srivastava et al. | Assessment of phenol and flavonoid content in the plant materials | |
Basniwal et al. | In-vitro antioxidant activity of hot aqueous extract of Helicteres isora Linn. fruits | |
Güder et al. | Antidiabetic and antioxidant properties of bilberry (Vaccinium myrtillus Linn.) fruit and their chemical composition. | |
Krishnasamy et al. | In vitro evaluation of antioxidant and antidiabetic activities of Syzygium densiflorum fruits | |
Liu et al. | Selenium-containing polysaccharides isolated from Rosa laevigata Michx fruits exhibit excellent anti-oxidant and neuroprotective activity in vitro | |
Ariffin et al. | In vitro antibacterial, antioxidant, and cytotoxicity evaluations of Musa paradisiaca cv. Sekaki florets from Sarawak, Malaysia | |
KR101041437B1 (ko) | 혈관질환 예방 또는 개선용 조성물 | |
KR101690779B1 (ko) | 홍삼농축분말 및 복분자완숙과추출물을 함유하는 발효물의 제조방법 및 상기 방법으로 제조된 발효물 | |
Huang et al. | Effect of lactic acid bacteria fermentation on antioxidation and bioactivity of hawthorn pulp | |
Lim et al. | Anti-oxidative and nitric oxide production inhibitory activities of phenolic compounds from the fruits of Actinidia arguta | |
KR20170003828A (ko) | 홍자단 추출물을 포함하는 항산화 또는 항염증 조성물 | |
KR101661491B1 (ko) | 삼채를 이용한 건강 기능이 강화된 야채수 제조 방법 | |
Lan et al. | Antioxidant and anti-tumor activities of purified polysaccharides with low molecular weights from Magnolia officinalis | |
Thinkratok et al. | Inhibitory potential of the rambutan rind extract and tannin against alpha-amylase and alpha-glucosidase activities in vitro | |
KR101428486B1 (ko) | 초임계 유체 추출법을 이용한 기능성이 증진된 클로렐라 추출물의 제조방법 | |
Raaman et al. | Anticancer and antioxidant activity of Curcuma zedoaria and Curcuma amada rhizome extracts | |
Ruen-ngam et al. | Evaluation of nutrient content and antioxidant, neuritogenic, and neuroprotective activities of upland rice bran oil. | |
Stanković et al. | Bioactive compounds from Taraxacum officinale extracts obtained by optimized ultrasound-assisted extraction | |
TWI520743B (zh) | 構樹樹皮半固態發酵產物之水溶性萃取物及其製法 | |
KR101844455B1 (ko) | 홍마늘을 포함한 항염증 음료 및 환 제조방법 | |
KR20170125191A (ko) | 아로니아 베리를 이용한 환 및 그의 제조방법 | |
Dabaghian et al. | Antimutagenicity and anticancer effects of Biebersteinia multifida DC | |
KR101646516B1 (ko) | 올리브잎, 연꽃씨, 연잎의 혼합 추출물을 포함하는 항산화 기능성 식품 조성물 | |
Shonekan et al. | ANTIOXIDANT AND GLUCOSIDASE INHIBITION ACTIVITIES OF THE MUSHROOM: †œPHAEOGYROPORUS PORTENTOSUS†|
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20140602 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150602 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20160509 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20170908 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20180823 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20190502 Year of fee payment: 9 |
|
R401 | Registration of restoration |